CFG
40
4
AEE
56
5
UPS
53
3
ROK
48
2
ILMN
32
2
EIX
62
3
LB
30
11
HBAN
47
3
COP
39
5
LNC
29
4
TXT
48
2
DHR
40
5
V
76
8
MAT
43
2
VNO
49
2
PNC
49
3
IBM
54
3
AMP
50
3
O
30
10
TROW
48
6
CFG
40
4
AEE
56
5
UPS
53
3
ROK
48
2
ILMN
32
2
EIX
62
3
LB
30
11
HBAN
47
3
COP
39
5
LNC
29
4
TXT
48
2
DHR
40
5
V
76
8
MAT
43
2
VNO
49
2
PNC
49
3
IBM
54
3
AMP
50
3
O
30
10
TROW
48
6
Financhill
Back

Excelerate Energy 10K Form

Sell
40

EE
Excelerate Energy

Last Price:
$30.51
Seasonality Move:
-13.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EE News And Ratings

See the #1 stock for the next 7 days that we like better than EE

EE Financial Statistics

Sales & Book Value

Annual Sales: $1.2B
Cash Flow: $28.3M
Price / Cash Flow: 8.16
Annual Sales: $20.34
Price / Book: 1.48

Profitability

EPS (TTM): 0.99000
Net Income (TTM): $25.7M
Gross Margin: $298.1M
Return on Equity: 1.4%
Return on Assets: 0.89%

Excelerate Energy Earnings Forecast

Key Excelerate Energy Financial Ratios

  • The Gross Profit Margin over the past 28 years for EE is 25.72%.
  • The Selling, General & Administrative Expenses for EE have been equal to 7.55% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 220.29% of Operating Income.
  • The Net Earning history of EE is 2.62% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 17 years.

Excelerate Energy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: EE
CUSIP: 283677
Website: excelerateenergy.com

Debt

Debt-to-Equity Ratio: 1.03
Current Ratio: 4.12
Quick Ratio: 4.03

Price-to-Earnings

Trailing P/E Ratio: 27.52
Forward P/E Ratio: 24.1

EE Technical Analysis vs Fundamental Analysis

Sell
40
Excelerate Energy (EE) is a Sell

Is Excelerate Energy a Buy or a Sell?

  • Excelerate Energy stock is rated a Sell
    The current Excelerate Energy [EE] share price is $30.55. The Score for EE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.